6505--36C26024Q0755 PLUVICTO LU 177 / RADIOPHARMACEUTICALS Clarification that vendors submitting quotes must have current Federal Supply Schedule Contract to be considered responsible. Procurement method FAR Part 8.
ID: 36C26024Q0755Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF260-NETWORK CONTRACT OFFICE 20 (36C260)VANCOUVER, WA, 98662, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/74c0b5760d614b6c953aa75e8018ea08/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified vendors to supply Lutetium Lu 177 PLUVICTO radiopharmaceuticals for the Portland VA Medical Center. Vendors must possess a current Federal Supply Schedule (FSS) contract to ensure their quotes are considered responsible, as outlined in the solicitation amendment. This procurement is crucial for treating metastatic castration-resistant prostate cancer, emphasizing the government's commitment to meeting the medical needs of veterans. Interested parties should submit their quotes by November 8, 2024, at 1:00 PM Pacific Time, and can direct inquiries to José Ronstadt at jose.ronstadt@va.gov or by phone at 360-852-9885.

    Point(s) of Contact
    Jose E Ronstadtjose.ronstadt@va.gov
    (360) 852-9885
    jose.ronstadt@va.gov
    Files
    Title
    Posted
    36C26024Q0755_1.docx
    The document is a Combined Synopsis/Solicitation Notice for the procurement of Lutetium Lu 177 PLUVICTO radiopharmaceuticals (27mCi/ML) for the Portland VA Medical Center. The contracting office is located in Vancouver, Washington, with a response deadline set for November 8, 2024, at 1:00 PM Pacific Time. The solicitation number for this request is 36C26024Q0755. The focus is on obtaining the specified radiopharmaceuticals or equivalent products, as detailed in the solicitation. Recovery Act funds are not involved, and the request falls under product service code 6505 and NAICS code 325412. Interested parties are encouraged to consult the solicitation document for comprehensive information about the required products and the place of performance. José Ronstadt of the VA is the designated point of contact for this solicitation. This notice emphasizes the government's ongoing efforts to meet the medical needs of veterans by facilitating the procurement of essential pharmaceuticals.
    36C26024Q0755 0001.docx
    The document is an amendment to a previous combined solicitation (36C26024Q0755) regarding the procurement of radiopharmaceuticals, specifically clarifying that vendors must possess a current Federal Supply Schedule (FSS) Contract for their quotes to be deemed responsible. The procurement will comply with the Federal Acquisition Regulation (FAR) Part 8 guidelines. The response deadline is set for November 8, 2024, at 13:00 Pacific Time, and the contracting office is located in Vancouver, Washington. The relevant product service code is 6505, and the NAICS code is 325412. The document emphasizes the necessity of the FSS contract to ensure compliance and accountability in the procurement process. This amendment reflects the protocols in government Requests for Proposals (RFPs), ensuring only qualified vendors participate, thereby enhancing the efficacy and integrity of the procurement system.
    52.212-2.docx
    The document outlines the evaluation criteria for contracts stemming from government solicitations related to commercial products and services. It specifies that the government will award contracts based on the most advantageous offer, taking into consideration technical acceptability and pricing. Offerors must possess a current Federal Supply Schedule (FSS) contract and meet requirements detailed in the Statement of Need. The overall evaluation will also include the total price for all options alongside the basic requirements, although the government is not obligated to exercise those options. Acceptance of offers will create a binding contract, regardless of further negotiations, unless a withdrawal is notified before the award. This provision emphasizes the structured approach of the government in managing procurements and ensuring responsible contracting while prioritizing efficiency and compliance in the evaluation process.
    S02 36C26024Q0755.docx
    The document outlines a Blanket Purchase Agreement (BPA) solicitation issued by the Department of Veterans Affairs for Lutetium Lu 177 PLUVICTO, a radiopharmaceutical used to treat metastatic castration-resistant prostate cancer. The BPA spans a base year from December 15, 2024, to December 14, 2025, with four additional one-year options, allowing the VA to purchase an estimated 60 doses annually based on patient needs. The contractor must abide by stringent regulations, including those from the Nuclear Regulatory Commission, while ensuring timely deliveries and quality controls. Key provisions include the requirement for direct delivery to the Portland VA Medical Center, with daily deliveries during specified hours, and waste disposal of radioactive materials at no extra charge. Additionally, the document emphasizes the contractor's obligations for quality assurance, confidentiality around defective products, and adherence to federal laws regarding radiopharmaceutical manufacturing standards. The contracting officer, José Ronstadt, serves as the contact for further inquiries. This BPA aims to establish a streamlined procurement process for essential medical supplies while maintaining compliance with related health and safety regulations.
    Similar Opportunities
    6505--VA Phoenix Pluvicto
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole-source contract for the procurement of Pluvicto (Lutetium Lu 177 Vipivotide Tetraxetan), a radiopharmaceutical therapy for treating metastatic castration-resistant prostate cancer, to Advanced Accelerator Applications USA. This procurement falls under FAR 8.405-6(a)(1)(B), which permits contracting with a single source capable of providing the unique and specialized services required. The contract is classified under NAICS code 325412, with a size standard of 1,300 employees, emphasizing the VA's commitment to delivering specialized healthcare solutions for veterans. Interested parties must submit a tailored capability statement by 10:00 AM PT on October 29, 2024, to Hestia Sim at Hestia.Sim@va.gov, including relevant company details and qualifications, as the government reserves the right to proceed with the award without competition if no responses are received.
    6550--VA Northern California Health Care System, Mather Radiopharmaceuticals & Radiopharmaceutical Supplies
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the provision of radiopharmaceuticals and related supplies for the VA Northern California Health Care System, specifically under solicitation number 36C26124Q0846. The contract will cover five ordering periods from April 1, 2025, to March 31, 2030, and requires contractors to deliver various radiopharmaceuticals while adhering to regulatory standards set by the Nuclear Regulatory Commission and the Food and Drug Administration. This procurement is crucial for ensuring reliable access to essential medical isotopes, which are vital for healthcare services provided to veterans. Interested contractors must submit their offers by October 28, 2024, at 12 PM PDT, and can direct inquiries to Contract Specialist Tawnya S Krommenhoek at tawnya.krommenhoek@va.gov. The contract has a minimum guaranteed value of $100 and a maximum total order value of $2.5 million.
    6505--VA Northern California Health Care System VA Medical Center - Martinez Radiopharmaceuticals & Radiopharmaceutical Supplies
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide radiopharmaceuticals and radiopharmaceutical supplies for the VA Northern California Health Care System, specifically for the VA Medical Center in Martinez. The procurement aims to ensure a reliable supply of essential radiopharmaceuticals for diagnostic and therapeutic procedures, with a focus on quality control and compliance with federal regulations. This contract spans five ordering periods from April 1, 2025, to March 31, 2030, with a guaranteed minimum award of $100 and a maximum aggregate order limit of $1,200,000. Interested parties can contact Contract Specialist Tawnya S Krommenhoek at tawnya.krommenhoek@va.gov for further details.
    770-25-1-801-0016 -National CMOP NALTREXONE -(VA-25-00010070)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Naltrexone tablets as part of a procurement initiative under solicitation number 36C77025Q0036. Vendors are required to submit their quotes by 4:00 PM CT on October 28, 2024, and must include essential documentation such as a signed SF1449 Solicitation cover page, a completed quote spreadsheet, and compliance with the Drug Supply Chain Security Act. This procurement is critical for ensuring the availability of pharmaceuticals necessary for the healthcare of veterans, reflecting the government's commitment to quality service. Interested vendors can contact Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162 for further information.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    F108--Radioactive Waste Removal Services
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified small businesses to provide Radioactive Waste Removal Services, specifically for the VA Boston Healthcare System. The procurement involves the collection and disposal of Low-Level Radioactive Waste (LLRW) generated from medical procedures, adhering to federal regulations and safety protocols. This initiative is crucial for maintaining effective waste management practices while ensuring compliance with environmental standards. Interested vendors must submit their quotes by November 8, 2024, and are required to be registered in the SAM and VetCert databases prior to contract award. For inquiries, potential bidders can contact the Contracting Officer, Tara Dossiema, via email at Tara.Dossiema@va.gov.
    6505-- Pegfilgrastim
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) numbered 36E79725R0001 for the procurement of Pegfilgrastim, aimed at ensuring a continuous supply for various entities including VA facilities, Consolidated Mail Order Pharmacies, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to a responsible offeror capable of providing Pegfilgrastim with a unique National Drug Code (NDC) and adhering to strict labeling guidelines, prohibiting the affixing of new labels over existing ones. The estimated annual requirement is for 8,458 syringes across multiple variants, with the RFP expected to be released electronically around November 5, 2024, and responses due by November 19, 2024. Interested parties should monitor sam.gov for updates and direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    6505--770-25-1-801-0013 - National CMOP CHLORHEXIDINE GLUCONATE 4% TOP LIQUID (VA-24-00109489)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of CHLORHEXIDINE GLUCONATE 4% TOP LIQUID for the National CMOP facility, under solicitation number VA-24-00109489. Vendors are required to submit a signed SF1449 cover page, a completed pricing schedule, and necessary licensing documents, ensuring compliance with federal regulations, including the Buy American Act and the Drug Supply Chain Security Act. This procurement is critical for providing quality pharmaceutical supplies to veterans, emphasizing the importance of adherence to strict acceptance criteria and logistical requirements. Quotes must be submitted by October 30, 2024, at 3:00 PM Central Time, and interested parties can contact Lacie A Nowak at lacie.nowak@va.gov for further information.
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    Q522-- Mobile CT Lung Cancer Screening
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 9, is seeking proposals for a Mobile CT Lung Cancer Screening service for the Mt. Home VAMC and Lexington VAMC CBOCs. This procurement aims to enhance lung cancer detection capabilities through mobile diagnostic imaging services, which are critical for timely and effective patient care. The solicitation has been amended to extend the deadline for submission of questions to October 10, 2024, at 10:00 AM CST, and all vendors must acknowledge receipt of this amendment to ensure their offers are considered. Interested parties should direct inquiries to Contract Specialist Christina Curley via email at christina.curley@va.gov, noting that phone calls are not accepted.